Savara, Inc. (SVRA)
5.27
-0.22
(-4.01%)
USD |
NASDAQ |
Mar 06, 16:00
5.30
+0.03
(+0.57%)
After-Hours: 20:00
Savara SG&A Expense (TTM) : 37.38M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ADMA Biologics, Inc. | 96.42M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Alnylam Pharmaceuticals, Inc. | 1.211B |
| BioMarin Pharmaceutical, Inc. | 1.153B |
| Imunon, Inc. | 7.011M |